News & Media

The Resilient Investor

2020
Investors Chronicle

The Drug Dreams Cause Euphoria

2020
Parkiet

5 Ways The World Fought Back

2020
GE

NPO Investing: Bigger Funds, Bigger Risks, Bigger Returns

2020
The Non Profit Times

How Often Do Vaccine Trials Hit Paydirt?

2020
Laboratory Equipment

MIT Sloan Study Shows Larger Nonprofit Endowment Funds Generate Higher Returns

2020
Third Sector

Coronavirus Vaccine Race Stirs $200 Billion Market Bubble

2020
Nouvelles Du Monde

Coronavirus Stokes $200 Billion Stock Market Bubble In Vaccines

2020
CBS News

Vaccines More Likely To Get Through Clinical Trials Than Other Types Of Drugs, MIT Study Finds

2020
The Boston Globe

Vaccines Find More Success in Development Than Any Other Kind of Drug, but …

2020
SciTechDaily

Vaccines More Likely to Get Through Clinical Trials Than Other Types of Drugs, MIT Study Finds

2020
MSN

Statistical Approach to COVID-19 Clinical Trials Aims to Accelerate Drug Approval Process

2020
Digital Health News

Statistical Approach to COVID-19 Clinical Trials Aims to Accelerate Drug Approval Process

2020
ACRP

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

2020
Pharmafile

MIT Researchers Describe New Methods For Accelerating Drug Approvals During Pandemics

2020
News Medical Life Sciences